Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Breast 1

Conditions

Multiple Myeloma 107Lymphoma 48Lymphoma, Non-Hodgkin 44Hodgkin Disease 44Leukemia, Myeloid, Acute 41Myelodysplastic Syndromes 40Leukemia 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Leukemia, Lymphocytic, Chronic, B-Cell 28Lymphoma, Mantle-Cell 26Neoplasms, Plasma Cell 25Lymphoma, Large B-Cell, Diffuse 24Lymphoma, Follicular 24Lymphoma, B-Cell, Marginal Zone 18Burkitt Lymphoma 18Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17Myeloproliferative Disorders 16Recurrence 14Immunoglobulin Light-chain Amyloidosis 14Congenital Abnormalities 13Primary Myelofibrosis 12Lymphoma, Large-Cell, Immunoblastic 12Leukemia, Myeloid, Accelerated Phase 12Hematologic Neoplasms 12Waldenstrom Macroglobulinemia 10Lymphoma, T-Cell, Cutaneous 10Leukemia, Myelomonocytic, Juvenile 10Leukemia, Myelomonocytic, Chronic 10Leukemia, Myeloid, Chronic-Phase 10Dendritic Cell Sarcoma, Interdigitating 10

Interventions

Paclitaxel 96Carboplatin 81Bevacizumab 62Gemcitabine 36liposomal doxorubicin 32pembrolizumab 30Topotecan 26olaparib 23Taxes 23niraparib 17Immunoglobulin G 17Disulfides 17Docetaxel 16Cyclophosphamide 16Cisplatin 14Nivolumab 11rucaparib 10durvalumab 10Doxorubicin 9Albumin-Bound Paclitaxel 8sargramostim 7pazopanib 7fludarabine phosphate 7fludarabine 7avelumab 7Magnetic Resonance Spectroscopy 7Ifosfamide 7epacadostat 6Trabectedin 6Sorafenib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Ovarian Neoplasms × Melphalan × Clear all
NCT00583622 2013-05-21

Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients

M.D. Anderson Cancer Center

Phase 2 Terminated
13 enrolled 5 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00523809 2013-01-28

Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor

M.D. Anderson Cancer Center

Phase 2 Terminated
5 enrolled 4 charts
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡